Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI)

被引：0
|
作者：
Cowzer, D. [1 ]
Capanu, M. [1 ]
Keane, F. [1 ]
Khalil, D. [1 ]
Shia, J. [1 ]
Do, R. [1 ]
Chou, J. [1 ]
Walch, H. [1 ]
El Dika, I. [1 ]
Yaqubie, A. [1 ]
Solit, D. [1 ]
Berger, M. [1 ]
O'Reilly, E. [1 ]
Harding, J. [1 ]
Abou-Alfa, G. [2 ,3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Cornell Univ, Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[3] Cornell Univ, Weill Med Coll, New York, NY USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.322
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-266
引用
收藏
页码：S109 / S109
页数：1
相关论文
共 50 条
  • [1] Patients (pts) with advanced hepatocellular carcinoma (HCC) with long-term response to immune checkpoint inhibitor (ICI) therapy
    Keane, F.
    Cowzer, D.
    Khalil, D.
    Shia, J.
    Do, R.
    Folorunso, S.
    El Dika, I.
    Yaqubie, A.
    Kim, T.
    O'Reilly, E.
    Abou-Alfa, G.
    Harding, J.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S111 - S112
  • [2] Outcomes with immune checkpoint inhibitors (ICI) in patients (pts) with MTAP alterations (alt) in advanced urothelial carcinoma (aUC).
    Talukder, Rafee
    Bakaloudi, Dimitra Rafailia
    Lin, Genevieve Ihsiu
    Enright, Tom
    Leary, Jacob Beck
    Makrakis, Dimitrios
    Tripathi, Nishita
    Agarwal, Neeraj
    Jindal, Tanya
    Koshkin, Vadim S.
    Brown, Jason R.
    Johnson, Jeffrey
    Zakharia, Yousef
    Park, Joseph J.
    Alva, Ajjai Shivaram
    Barrera, Rafael Morales
    Drakaki, Alexandra
    Barata, Pedro C.
    Khaki, Ali Raza
    Grivas, Petros
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Real-world experience and outcomes of immune-checkpoint inhibitors (ICI) in hepatocellular carcinoma (HCC)
    Paul, Samuel
    Min, Eric
    Benson, Katherine K.
    Xu, Menglin
    Noonan, Anne M.
    Mittra, Arjun
    Malalur, Pannaga G.
    Roychowdhury, Sameek
    Jin, Ning
    Hays, John L.
    Elkhatib, Rifat T.
    Rahman, Shafia
    Miller, Eric David
    Pardo, Dayssy Alexandra Diaz
    Manne, Ashish
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Outcomes of beta blockers (BB) in hepatocellular carcinoma (HCC) treated with immune checkpoint inhibitors (ICIs)
    Wu, Linda
    Ozbek, Umut
    van Hyfte, Grace
    Reincke, Marlene
    Gampa, Anuhya
    Abugabal, Yehia I.
    Nishida, Naoshi
    Wietharn, Brooke
    Amara, Suneetha
    Balcar, Lorenz
    Pinter, Matthias
    Vogel, Arndt
    Weinmann, Arndt
    Saeed, Anwaar
    Rimassa, Lorenza
    Naqash, Abdul Rafeh
    Muzaffar, Mahvish
    Huang, Yi-Hsiang
    Pinato, David James
    Ang, Celina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [5] Clinical outcomes of EGFR plus NSCLC pts treated with immune checkpoint inhibitors (ICI).
    Piotrowska, Zofia
    Cobb, Rosemary G.
    Banwait, Mandeep
    Marcoux, Nicolas
    Mooradian, Meghan
    Dagogo-Jack, Ibiayi
    Lin, Jessica Jiyeong
    Heist, Rebecca Suk
    Shaw, Alice Tsang
    Gainor, Justin F.
    Sequist, Lecia V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
    Wu, Y. Linda
    van Hyfte, Grace
    Ozbek, Umut
    Reincke, Marlene
    Gampa, Anuhya
    Mohamed, Yehia I.
    Nishida, Naoshi
    Wietharn, Brooke
    Amara, Suneetha
    Lee, Pei-Chang
    Scheiner, Bernhard
    Balcar, Lorenz
    Pinter, Matthias
    Vogel, Arndt
    Weinmann, Arndt
    Saeed, Anwaar
    Pillai, Anjana
    Rimassa, Lorenza
    Naqash, Abdul Rafeh
    Muzaffar, Mahvish
    Huang, Yi-Hsiang
    Kaseb, Ahmed O.
    Kudo, Masatoshi
    Pinato, David J.
    Ang, Celina
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] International, open-label phase 2 study of regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinoma (HCC) previously treated with immune checkpoint inhibitors (ICI)
    El-Khoueiry, Anthony B.
    Kim, Tae-You
    Blanc, Jean-Frederic
    Rosmorduc, Olivier
    Decaens, Thomas
    Mathurin, Philippe
    Merle, Philippe
    Dayyani, Farshid
    Masi, Gianluca
    Pressiani, Tiziana
    Galle, Peter Robert
    Hatogai, Ken
    Ishii, Yuko
    Seidel, Henrik
    Mueller, Udo
    Kalambakas, Stacey Anastasia
    Bouattour, Mohamed
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Impact of metformin on clinical outcomes in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors.
    Khalil, Lana
    Kang, Sandra
    McCook-Veal, Ashley
    Draper, Amber
    Diab, Maria
    Shaib, Walid Labib
    Alese, Olatunji B.
    El-Rayes, Bassel F.
    Akce, Mehmet
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors
    Chen, Krista Y.
    Popovic, Aleksandra
    Hsiehchen, David
    Baretti, Marina
    Griffith, Paige
    Bista, Ranjan
    Baghdadi, Azarakhsh
    Kamel, Ihab R.
    Simon, Sanford M.
    Migler, Rachael D.
    Yarchoan, Mark
    [J]. CANCERS, 2022, 14 (21)
  • [10] Outcomes of Lynch syndrome (LS) patients treated with immune checkpoint inhibitors (ICI).
    Bari, Shahla
    Kim, Richard D.
    Wang, Xia
    Matejcic, Marco
    Muzaffar, Jameel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345